Candida parapsilosis: from Genes to the Bedside

RNA-Seq: a revolutionary tool for transcriptomics

Wang, Z., Gerstein, M., & Snyder, M. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2484 · Cited by 13,174

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200

International Study of the Prevalence and Outcomes of Infection in Intensive Care Units

Vincent, J. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,639

Evolution of pathogenicity and sexual reproduction in eight Candida genomes

Butler, G., Rasmussen, M. D., Lin, M. F., Santos, M. A. S., Sakthikumar, S., Munro, C. A., Rheinbay, E., Grabherr, M., Forche, A., Reedy, J. L., et al. (2009) · Nature · doi:10.1038/nature08064 · Cited by 1,065

Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis

Conti, H. R., Shen, F., Nayyar, N., Stocum, E., Sun, J. N., Lindemann, M. J., Ho, A. W., Hai, J. H., Yu, J. J., Jung, J. W., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081463 · Cited by 1,024 · cited 1×

Candidalysin is a fungal peptide toxin critical for mucosal infection

Moyes, D. L., Wilson, D., Richardson, J. P., Mogavero, S., Tang, S. X., Wernecke, J., Hoefs, S., Gratacap, R. L., Robbins, J., Runglall, M., et al. (2016) · Nature · doi:10.1038/nature17625 · Cited by 928

Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species

Whaley, S. G., Berkow, E. L., Rybak, J. M., Nishimoto, A. T., Barker, K. S., & Rogers, P. D. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02173 · Cited by 900

Potential Role of Phospholipases in Virulence and Fungal Pathogenesis

Ghannoum, M. A. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.1.122-143.2000 · Cited by 823

Amphotericin B formulations: a comparative review of efficacy and toxicity

Hamill, R. J. (2013) · Drugs · doi:10.1007/s40265-013-0069-4 · Cited by 807

Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins

Kuhn, D. M., George, T., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1773-1780.2002 · Cited by 775

COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions?

Arastehfar, A. A., Carvalho, A., Nguyen, M. H., Hedayati, M. T., Netea, M. G., Perlin, D. S., & Hoenigl, M. (2020) · Journal of Fungi · doi:10.3390/jof6040211 · Cited by 276

Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap

Daneshnia, F., de Almeida Júnior, J. N., Ilkit, M., Lombardi, L., Perry, A. M., Gao, M., Nobile, C. J., Egger, M., Perlin, D. S., Zhai, B., et al. (2023) · The Lancet Microbe · doi:10.1016/s2666-5247(23)00067-8 · Cited by 257

The Quiet and Underappreciated Rise of Drug-Resistant Invasive Fungal Pathogens

Arastehfar, A., Lass-Flörl, C., Garcia-Rubio, R., Daneshnia, F., Ilkit, M., Boekhout, T., Gabaldon, T., & Perlin, D. S. (2020) · Journal of Fungi · doi:10.3390/jof6030138 · Cited by 145

The changing epidemiology of fungal infections

Lass‐Flörl, C., & Steixner, S. J. M. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101215 · Cited by 129

First Report of Candidemia Clonal Outbreak Caused by Emerging Fluconazole-Resistant Candida parapsilosis Isolates Harboring Y132F and/or Y132F+K143R in Turkey

Arastehfar, A. A., Daneshnia, F., Polat, S. H., Fang, W., Yaşar, M., Polat, F., Metin, D. Y., Rigole, P., Coenye, T., İlkit, M., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01001-20 · Cited by 112

Mechanisms of Pathogenic Candida Species to Evade the Host Complement Attack

Singh, D. K., Tóth, R., & Gácser, A. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00094 · Cited by 118

Gut mycobiota alterations in patients with COVID-19 and H1N1 infections and their associations with clinical features

Lv, L., Gu, S., Jiang, H., Ren, Y., Chen, Y., Chen, Y., Luo, R., Huang, C., Lu, H., Zheng, B., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02036-x · Cited by 104

Green Approach to Overcome the Resistance Pattern of Candida spp. Using Biosynthesized Silver Nanoparticles Fabricated by Penicillium chrysogenum F9

Soliman, A. M., Abdel-Latif, W., Shehata, I. H., Fouda, A., Abdo, A. M., & Ahmed, Y. M. (2020) · Biological Trace Element Research · doi:10.1007/s12011-020-02188-7 · Cited by 99

Environmental Clonal Spread of Azole-Resistant Candida parapsilosis with Erg11-Y132F Mutation Causing a Large Candidemia Outbreak in a Brazilian Cancer Referral Center

Thomaz, D. Y., de Almeida, J. N., Sejas, O. N. E., Negro, G. M. B. D., Carvalho, G. O. M. H., Gimenes, V. M. F., de Souza, M. E. B., Arastehfar, A. A., Camargo, C. H., Motta, A. L., et al. (2021) · Journal of Fungi · doi:10.3390/jof7040259 · Cited by 100

Candidiasis and Other Emerging Yeasts

Sharma, M., & Chakrabarti, A. (2023) · Current Fungal Infection Reports · doi:10.1007/s12281-023-00455-3 · Cited by 110

Candidemia: Evolution of Drug Resistance and Novel Therapeutic Approaches

Tortorano, A. M., Prigitano, A., Morroni, G., Brescini, L., & Barchiesi, F. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s274872 · Cited by 104

Clonal Candidemia Outbreak by Candida parapsilosis Carrying Y132F in Turkey: Evolution of a Persisting Challenge

Arastehfar, A. A., Polat, S. H., Daneshnia, F., Pan, W., Hafez, A. I., Fang, W., Liao, W., Şahbudak-Bal, Z., Metin, D. Y., de Almeida, J. N., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.676177 · Cited by 86

Prevalence and Clonal Distribution of Azole-Resistant Candida parapsilosis Isolates Causing Bloodstream Infections in a Large Italian Hospital

Martini, C., Torelli, R., de Groot, T., Carolis, E. D., Morandotti, G. A., Angelis, G. D., Posteraro, B., Meis, J. F. G. M., & Sanguinetti, M. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00232 · Cited by 85

Current Aspects in the Biology, Pathogeny, and Treatment of Candida krusei, a Neglected Fungal Pathogen

Gómez-Gaviria, M., & Mora-Montes, H. M. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s247944 · Cited by 93

Candida parapsilosis complex in the clinical setting

Govrins, M. A., & Lass‐Flörl, C. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00961-8 · Cited by 83

Evaluation of Molecular Epidemiology, Clinical Characteristics, Antifungal Susceptibility Profiles, and Molecular Mechanisms of Antifungal Resistance of Iranian Candida parapsilosis Species Complex Blood Isolates

Arastehfar, A. A., Daneshnia, F., Najafzadeh, M. J., Hagen, F., Mahmoudi, S., Salehi, M., Zarrinfar, H., Namvar, Z., Zareshahrabadi, Z., Khodavaisy, S., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00206 · Cited by 70

A Brazilian Inter-Hospital Candidemia Outbreak Caused by Fluconazole-Resistant Candida parapsilosis in the COVID-19 Era

Thomaz, D. Y., Negro, G. M. B. D., Ribeiro, L. B., da Silva, M., Carvalho, G. O. M. H., Camargo, C. H., de Almeida, J. N., Motta, A. L., Siciliano, R. F., Sejas, O. N. E., et al. (2022) · Journal of Fungi · doi:10.3390/jof8020100 · Cited by 65

Understanding the mechanisms of resistance to azole antifungals in Candida species

Li, Y., Hind, C. K., Furner-Pardoe, J., Sutton, J. M., & Rahman, K. M. (2025) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaf106 · Cited by 70

Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China

Ning, Y., Xiao, M., Perlin, D. S., Zhao, Y., Lu, M., Li, Y., Luo, Z., Dai, R., Li, S., Xu, J., et al. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2153086 · Cited by 63

Non-albicans Candida Species: Immune Response, Evasion Mechanisms, and New Plant-Derived Alternative Therapies

Gómez-Gaviria, M., Ramírez-Sotelo, U., & Mora-Montes, H. M. (2022) · Journal of Fungi · doi:10.3390/jof9010011 · Cited by 72

Antifungal heteroresistance causes prophylaxis failure and facilitates breakthrough Candida parapsilosis infections

Zhai, B., Liao, C., Jaggavarapu, S., Tang, Y., Rolling, T., Ning, Y., Sun, T., Bergin, S. A., Gjonbalaj, M., Miranda, E., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03183-4 · Cited by 62

General hospital outbreak of invasive candidiasis due to azole-resistant Candida parapsilosis associated with an Erg11 Y132F mutation

Corzo-León, D., Peacock, M., Rodríguez‐Zulueta, P., Salazar-Tamayo, G., & MacCallum, D. M. (2020) · Medical Mycology · doi:10.1093/mmy/myaa098 · Cited by 58

Global Emergence of Resistance to Fluconazole and Voriconazole in Candida parapsilosis in Tertiary Hospitals in Spain During the C OVID-19 Pandemic

Trevijano-Contador, N., Torres-Cano, A., Carballo-González, C., Puig-Asensio, M., Martín-Gómez, M. T., Jiménez-Martínez, E., Romero, D., Nuvials, F. X., Olmos-Arenas, R., Moretó-Castellsagué, M. C., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac605 · Cited by 54

Candida lusitaniae: Biology, Pathogenicity, Virulence Factors, Diagnosis, and Treatment

Mendoza-Reyes, D. F., Gómez-Gaviria, M., & Mora-Montes, H. M. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s383785 · Cited by 61

Impact of the COVID-19 Pandemic on the Clinical Profile of Candidemia and the Incidence of Fungemia Due to Fluconazole-Resistant Candida parapsilosis

Ramos, A., Pintos-Pascual, I., Guinea, J., Gutiérrez‐Villanueva, A., Abreu, E. V. G., Díaz-García, J., Asensio, Á., Iranzo, R., Sánchez‐Romero, I., Muñoz‐Algarra, M., et al. (2022) · Journal of Fungi · doi:10.3390/jof8050451 · Cited by 53

Genetically related micafungin-resistant Candida parapsilosis blood isolates harbouring novel mutation R658G in hotspot 1 of Fks1p: a new challenge?

Arastehfar, A. A., Daneshnia, F., Polat, S. H., İlkit, M., Yaşar, M., Polat, F., Metin, D. Y., Dökümcü, Z., Pan, W., Hagen, F., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa419 · Cited by 52

Evidence of Fluconazole-Resistant Candida parapsilosis Genotypes Spreading across Hospitals Located in Madrid, Spain and Harboring the Y132F ERG11p Substitution

Díaz-García, J., Gómez, A., Alcalá, L., Reigadas, E., Sánchez‐Carrillo, C., Pérez‐Ayala, A., de la Pedrosa, E. G., González‐Romo, F., Amador, P. M., Cuétara, M. S., et al. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00710-22 · Cited by 52

Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System In Vitro

Spaggiari, L., Sala, A., Ardizzoni, A., Seta, F. D., Singh, D. K., Gácser, A., Blasi, E., & Pericolini, E. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02696-21 · Cited by 56

Increasing Incidence and Shifting Epidemiology of Candidemia in Greece: Results from the First Nationwide 10-Year Survey

Mamali, V., Siopi, M., Charpantidis, S., Samonis, G., Tsakris, A., Vrioni, G., & on behalf of the Candi-Candi Network (2022) · Journal of Fungi · doi:10.3390/jof8020116 · Cited by 52

Functional Characterization of Secreted Aspartyl Proteases in Candida parapsilosis

Singh, D. K., Németh, T., Papp, A., Tóth, R., Lukácsi, S., Hrušková‐Heidingsfeldová, O., Dostál, J., Vágvölgyi, C., Bajtay, Z., Józsi, M., et al. (2019) · mSphere · doi:10.1128/msphere.00484-19 · Cited by 52

COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave

Bretagne, S., Sitbon, K., Botterel, F., Dellière, S., Letscher‐Bru, V., Chouaki, T., Bellanger, A., Bonnal, C., Fekkar, A., Persat, F., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.01138-21 · Cited by 49

Determinants of fluconazole resistance and echinocandin tolerance in C. parapsilosis isolates causing a large clonal candidemia outbreak among COVID-19 patients in a Brazilian ICU

Daneshnia, F., de Almeida, J. N., Arastehfar, A. A., Lombardi, L., Shor, E., Moreno, L., Mendes, A. V. A., Barberino, M. G., Thomaz, D. Y., Butler, G., et al. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2117093 · Cited by 47

Candida parapsilosis : A systematic review to inform the World Health Organization fungal priority pathogens list

Asogan, M., Kim, H. Y., Kidd, S. E., Alastruey‐Izquierdo, A., Govender, N. P., Dao, A., Shin, J.-H., Heim, J., Ford, N. P., Gigante, V., et al. (2023) · Medical Mycology · doi:10.1093/mmy/myad131 · Cited by 44

Triazole Evolution of Candida parapsilosis Results in Cross-Resistance to Other Antifungal Drugs, Influences Stress Responses, and Alters Virulence in an Antifungal Drug-Dependent Manner

Papp, C., Bohner, F., Kocsis, K., Varga, M., Szekeres, A., Bodai, L., Willis, J. R., Gabaldón, T., Tóth, R., Nosanchuk, J. D., et al. (2020) · mSphere · doi:10.1128/msphere.00821-20 · Cited by 42

Opportunistic yeast pathogen Candida spp.: Secreted and membrane-bound virulence factors

Lim, S. J., Ali, M. S. M., Sabri, S., Noor, N. D. M., Salleh, A. B., & Oslan, S. N. (2021) · Medical Mycology · doi:10.1093/mmy/myab053 · Cited by 43

Emergence of resistantCandida glabratain Germany

Aldejohann, A. M., Herz, M., Martin, R., Walther, G., & Kurzai, O. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab122 · Cited by 43

Recent Increase in the Prevalence of Fluconazole-Non-susceptible Candida tropicalis Blood Isolates in Turkey: Clinical Implication of Azole-Non-susceptible and Fluconazole Tolerant Phenotypes and Genotyping

Arastehfar, A., Hilmioğlu-Polat, S., Daneshnia, F., Hafez, A., Salehi, M., Polat, F., Yaşar, M., Arslan, N., Hoşbul, T., Ünal, N., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.587278 · Cited by 40

The Candida Genome Database: annotation and visualization updates

Lew-Smith, J., Binkley, J., & Sherlock, G. (2025) · Genetics · doi:10.1093/genetics/iyaf001 · Cited by 37

Early Virulence Predictors during the Candida Species–Galleria mellonella Interaction

García-Carnero, L. C., Clavijo-Giraldo, D. M., Gómez-Gaviria, M., Lozoya‐Pérez, N. E., Tamez-Castrellón, A. K., López-Ramírez, L. A., & Mora-Montes, H. M. (2020) · Journal of Fungi · doi:10.3390/jof6030152 · Cited by 39

Metagenomic profiling of hospital wastewater: A comprehensive national scale analysis of antimicrobial resistance genes and opportunistic pathogens

Silvester, R., Perry, W. B., Webster, G., Rushton, L., Baldwin, A. J., Pass, D. A., Byrnes, N. A., Farkas, K., Heginbothom, M. L., Craine, N., et al. (2025) · Journal of Infection · doi:10.1016/j.jinf.2025.106503 · Cited by 37

Candida parapsilosis Mdr1B and Cdr1B Are Drivers of Mrr1-Mediated Clinical Fluconazole Resistance

Doorley, L. A., Rybak, J. M., Berkow, E. L., Zhang, Q. H., Morschhäuser, J., & Rogers, P. D. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00289-22 · Cited by 34

Candida blood stream infections observed between 2011 and 2016 in a large Italian University Hospital: A time-based retrospective analysis on epidemiology, biofilm production, antifungal agents consumption and drug-susceptibility

Brunetti, G., Navazio, A. S., Giuliani, A., Giordano, A., Proli, E. M., Antonelli, G., & Raponi, G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224678 · Cited by 39

Species distribution, azole resistance and related molecular mechanisms in invasive Candida parapsilosis complex isolates: Increase in fluconazole resistance in 21 years

Demirci‐Duarte, S., Arıkan-Akdağlı, S., & Gülmez, D. (2021) · Mycoses · doi:10.1111/myc.13296 · Cited by 36

Metagenomic Investigation of Ticks From Kenyan Wildlife Reveals Diverse Microbial Pathogens and New Country Pathogen Records

Ergünay, K., Mutinda, M., Bourke, B. P., Justi, S. A., Caicedo-Quiroga, L., Kamau, J., Mutura, S., Karegi, I., Cook, E. A. J., Gakuya, F., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.932224 · Cited by 36

Pan-Echinocandin Resistant C. parapsilosis Harboring an F652S Fks1 Alteration in a Patient with Prolonged Echinocandin Therapy

Siopi, M., Papadopoulos, A., Spiliopoulou, A., Paliogianni, F., Abou‐Chakra, N., Arendrup, M. C., Damoulari, C., Tsioulos, G., Giannitsioti, E., Frantzeskaki, F. G., et al. (2022) · Journal of Fungi · doi:10.3390/jof8090931 · Cited by 36

Candida spp. in Human Intestinal Health and Disease: More than a Gut Feeling

Kreulen, I. A. M., de Jonge, W. J., van den Wijngaard, R. M., & van Thiel, I. A. M. (2023) · Mycopathologia · doi:10.1007/s11046-023-00743-z · Cited by 37

Genomic reconstruction of an azole-resistant Candida parapsilosis outbreak and the creation of a multi-locus sequence typing scheme: a retrospective observational and genomic epidemiology study

Brassington, P. J. T., Klefisch, F.-R., Graf, B., Pfüller, R., Kurzai, O., Walther, G., & Barber, A. E. (2024) · The Lancet Microbe · doi:10.1016/j.lanmic.2024.07.012 · Cited by 37

Candida Pathogenicity and Interplay with the Immune System

Valand, N., & Girija, U. V. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-67452-6_11 · Cited by 38

Tracing the Origin of Invasive Fungal Infections

Papon, N., Bougnoux, M., & d’Enfert, C. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2020.01.007 · Cited by 33

Genotyping Reveals High Clonal Diversity and Widespread Genotypes of Candida Causing Candidemia at Distant Geographical Areas

Guinea, J., Arendrup, M. C., Cantón, R., Cantón, E., García‐Rodríguez, J., Gómez, A., de la Pedrosa, E. G. G., Hare, R. K., Orden, B., Sanguinetti, M., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00166 · Cited by 34

Candida Empyema Thoracis at Two Academic Medical Centers: New Insights Into Treatment and Outcomes

Senger, S. S., Thompson, G. R., Samanta, P., Ahrens, J., Clancy, C. J., & Nguyen, M. H. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa656 · Cited by 37

Physiological and Transcriptional Responses of Candida parapsilosis to Exogenous Tyrosol

Jakab, Á., Tóth, Z., Nagy, F., Nemes, D., Bácskay, I., Kardos, G., Emri, T., Pócsi, I., Majoros, L., & Kovács, R. (2019) · Applied and Environmental Microbiology · doi:10.1128/aem.01388-19 · Cited by 32

Antifungal and Antibiofilm Activity of Cyclic Temporin L Peptide Analogues against Albicans and Non-Albicans Candida Species

Bellavita, R., Maione, A., Merlino, F., Siciliano, A., Dardano, P., Stefano, L. D., Galdiero, S., Galdiero, E., Grieco, P., & Falanga, A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020454 · Cited by 31

Paradigm Shift: Candida parapsilosis sensu stricto as the Most Prevalent Candida Species Isolated from Bloodstream Infections with Increasing Azole-Non-Susceptibility Rates: Trends from 2015–2022 Survey

Franconi, I., Rizzato, C., Tavanti, A., Falcone, M., & Lupetti, A. (2023) · Journal of Fungi · doi:10.3390/jof9101012 · Cited by 34

Moonlighting proteins in medically relevant fungi

Arvizu-Rubio, V., García-Carnero, L. C., & Mora-Montes, H. M. (2022) · PeerJ · doi:10.7717/peerj.14001 · Cited by 33

Distribution, trends, and antifungal susceptibility of Candida species causing candidemia in Japan, 2010–2019: A retrospective observational study based on national surveillance data

Kajihara, T., Yahara, K., Nagi, M., Kitamura, N., Hirabayashi, A., Hosaka, Y., Abe, M., Miyazaki, Y., & Sugai, M. (2022) · Medical Mycology · doi:10.1093/mmy/myac071 · Cited by 29

Iron Metabolism, Pseudohypha Production, and Biofilm Formation through a Multicopper Oxidase in the Human-Pathogenic Fungus Candida parapsilosis

Chakraborty, T., Tóth, Z., Tóth, R., Vágvölgyi, C., & Gácser, A. (2020) · mSphere · doi:10.1128/msphere.00227-20 · Cited by 27

High colonization by Candida parapsilosis sensu stricto on hands and surfaces in an adult intensive care unit

da Silva, E. M., Mansano, E. S. B., Mendonca, P., Olegário, R., Tobaldini-Valério, F. K., Fiorini, A., & Svidzinski, T. I. E. (2021) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2020.101110 · Cited by 28

Evaluation of Autof MS 1000 and Vitek MS MALDI-TOF MS System in Identification of Closely-Related Yeasts Causing Invasive Fungal Diseases

Yi, Q., Xiao, M., Fan, X., Zhang, G., Yang, Y., Zhang, J., Duan, S., Cheng, J., Li, Y., Zhou, M., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.628828 · Cited by 28

How does temperature trigger biofilm adhesion and growth in Candida albicans and two non‐Candida albicans Candida species?

Pierantoni, D. C., Corte, L., Casadevall, A., Robert, V., Cardinali, G., & Tascini, C. (2021) · Mycoses · doi:10.1111/myc.13291 · Cited by 29

Aneuploidy Underlies Tolerance and Cross-Tolerance to Drugs in Candida parapsilosis

Yang, F. J., Lu, H., Wu, H., Fang, T., Berman, J. G., & Jiang, Y. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00508-21 · Cited by 26

Antifungal Effect and Inhibition of the Virulence Mechanism of D-Limonene against Candida parapsilosis

de Andrade, M. C. L., Neto, L. N. D. A., Buonafina, M. D. S., dos Santos, F. D. A. G., Alves, A. I. D. S., de Castro, M. C. A. B., Mori, E., de Lacerda, B. C. G. V., Araújo, I. M., Coutinho, H. D. M., et al. (2022) · Molecules · doi:10.3390/molecules27248884 · Cited by 27

Glucose - The X factor for the survival of human fungal pathogens and disease progression in the host

Qadri, H., Qureshi, M. F., Mir, M. A., & Shah, A. H. (2021) · Microbiological Research · doi:10.1016/j.micres.2021.126725 · Cited by 27

Impact of Fluconazole Resistance on the Outcomes of Patients With Candida parapsilosis Bloodstream Infections: A Retrospective Multicenter Study

Vena, A., Tiseo, G., Falcone, M., Bartalucci, C., Marelli, C., Cesaretti, M., Pilato, V. D., Escribano, P., Forniti, A., Giacobbe, D. R., et al. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciae603 · Cited by 26

Prevalence and Antifungal Susceptibility of Candida parapsilosis Species Complex in Eastern China: A 15-Year Retrospective Study by ECIFIG

Guo, J., Zhang, M., Qiao, D., Shen, H., Wang, L., Wang, D., Li, L., Liu, Y., Lu, H., Wang, C., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.644000 · Cited by 27

Candida parapsilosis Sensu Stricto Antifungal Resistance Mechanisms and Associated Epidemiology

Franconi, I., Rizzato, C., Poma, N. V., Tavanti, A., & Lupetti, A. (2023) · Journal of Fungi · doi:10.3390/jof9080798 · Cited by 27

Clinical azole cross-resistance in Candida parapsilosis is related to a novel MRR1 gain-of-function mutation

Branco, J., Ryan, A. P., Silva, A. P., Butler, G., Miranda, I. M., & Rodrigues, A. G. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.08.014 · Cited by 25

Molecular Characterization of Candida parapsilosis by Microsatellite Typing and Emergence of Clonal Antifungal Drug Resistant Strains in a Multicenter Surveillance in China

Zhang, L., Yu, S.-Y., Chen, S. C.-A., Xiao, M., Kong, F., Wang, H., Ning, Y., Lu, M., Sun, T., Hou, X., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01320 · Cited by 24

Mutations in TAC1 and ERG11 are major drivers of triazole antifungal resistance in clinical isolates of Candida parapsilosis

Doorley, L. A., Barker, K. S., Zhang, Q., Rybak, J. M., & Rogers, P. D. (2023) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2023.08.030 · Cited by 23

Toxic, Radical Scavenging, and Antifungal Activity of Rhododendron tomentosum H. Essential Oils

Judžentienė, A., Būdienė, J., Švedienė, J., & Garjonytė, R. (2020) · Molecules · doi:10.3390/molecules25071676 · Cited by 23

Persistent candidemia caused by different Candida species: Data from a multicenter contemporary cohort

Tiseo, G., Vena, A., Bassetti, M., Bartalucci, C., Cerchiaro, M., Cesaretti, M., Marchese, A. E., Pilato, V. D., Escribano, P., Forniti, A., et al. (2025) · Journal of Infection · doi:10.1016/j.jinf.2025.106586 · Cited by 22

Synthesis, Structure, and Activity of the Antifungal Plant Defensin PvD1

Skalska, J., de Andrade, V. M., de Cena, G. L., Harvey, P. J., Gaspar, D., Mello, É. D. O., Henriques, S. T., Valle, J., Gomes, V. M., Conceição, K., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00543 · Cited by 21

Molecular and Epidemiological Investigation of Fluconazole-resistant Candida parapsilosis —Georgia, United States, 2021

Misas, E., Witt, L. S., Farley, M. M., Thomas, S., Jenkins, E. N., Gade, L., Peterson, J. G., Restrepo, A. M., Fridkin, S. K., Lockhart, S. R., et al. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae264 · Cited by 22

Candida parapsilosis Colony Morphotype Forecasts Biofilm Formation of Clinical Isolates

Gómez-Molero, E., De-la-Pinta, I., Fernández-Pereira, J., Groß, U., Weig, M., Quindós, G., de Groot, P. W. J., & Bader, O. (2021) · Journal of Fungi · doi:10.3390/jof7010033 · Cited by 22

Biochemical and structural characterization of enzymes in the 4-hydroxybenzoate catabolic pathway of lignin-degrading white-rot fungi

Kuatsjah, E., Schwartz, A., Zahn, M., Tornesakis, K., Kellermyer, Z. A., Ingraham, M. A., Woodworth, S. P., Ramirez, K. J., Cox, P. A., Pickford, A. R., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115002 · Cited by 20

First Canadian report of transmission of fluconazole-resistant Candida parapsilosis within two hospital networks confirmed by genomic analysis

McTaggart, L. R., Eshaghi, A., Hota, S. S., Poutanen, S. M., Johnstone, J., Luca, D. G. D., Bharat, A., Patel, S. N., & Kus, J. V. (2023) · Journal of Clinical Microbiology · doi:10.1128/jcm.01161-23 · Cited by 19

Intravital Imaging Reveals Divergent Cytokine and Cellular Immune Responses to Candida albicans and Candida parapsilosis

Archambault, L. S., Trzilova, D., Gonia, S., Gale, C. A., & Wheeler, R. T. (2019) · mBio · doi:10.1128/mbio.00266-19 · Cited by 19

Characterisation of Candida parapsilosis CYP51 as a Drug Target Using Saccharomyces cerevisiae as Host

Ruma, Y. N., Keniya, M. V., Tyndall, J. D. A., & Monk, B. C. (2022) · Journal of Fungi · doi:10.3390/jof8010069 · Cited by 21

Voriconazole-Natural Latex Dressings for Treating Infected Candida Spp. Skin Ulcers

da Silva, T. V., de Barros, N. R., Costa-Orlandi, C. B., Tanaka, J. L., Moro, L. G., Brasil, G. S. P., Oliveira, K. S. M., Mendes‐Giannini, M. J. S., Fusco‐Almeida, A. M., & Herculano, R. D. (2020) · Future Microbiology · doi:10.2217/fmb-2020-0122 · Cited by 19

Antimicrobial Peptides Pom-1 and Pom-2 from Pomacea poeyana Are Active against Candidaauris, C. parapsilosis and C. albicans Biofilms

Raber, H. F., Sejfijaj, J., Kissmann, A., Wittgens, A., González-García, M., Alba, A., Vázquez, A. A., Morales-Vicente, F., Perez‐Erviti, J. A., Kubiczek, D. H., et al. (2021) · Pathogens · doi:10.3390/pathogens10040496 · Cited by 20

Epidemiology of Candidemia in Children over 7 Years in a Medical Center in Turkey

Çiftdoğan, D. Y., Aksay, A. K., Erbaş, G., Sarkış, Ü. B., Öncel, E. K., Anıl, A. B., Baran, M., Er, H., & Yılmaz, N. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00453-21 · Cited by 18

High Incidence of Candidemia in Critically Ill COVID-19 Patients Supported by Veno-Venous Extracorporeal Membrane Oxygenation: A Retrospective Study

Alessandri, F., Ceccarelli, G., Migliara, G., Baccolini, V., Russo, A., Marzuillo, C., Ceparano, M., Giordano, G. G., Tozzi, P., Galardo, G., et al. (2023) · Journal of Fungi · doi:10.3390/jof9010119 · Cited by 19

The Fourier-transform infrared spectroscopy-based method as a new typing tool for Candida parapsilosis clinical isolates

Carolis, E. D., Posteraro, B., Falasca, B., Spruijtenburg, B., Meis, J. F. G. M., & Sanguinetti, M. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02388-23 · Cited by 19

Synthesis, structure–activity relationship and biological evaluation of indole derivatives as anti-Candida albicans agents

Wu, Y., Sun, A., Chen, F., Zhao, Y., Zhu, X., Zhang, T., Ni, G., & Wang, R. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107293 · Cited by 19

Analysis of clinical Candida parapsilosis isolates reveals copy number variation in key fluconazole resistance genes

Bergin, S. A., Doorley, L. A., Rybak, J. M., Wolfe, K. H., Butler, G., Cuomo, C. A., & Rogers, P. D. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01619-23 · Cited by 19

Ethnobotanical study of Hakka traditional medicine in Ganzhou, China and their antibacterial, antifungal, and cytotoxic assessments

Hu, H., Yang, Y., Aissa, A., Tekin, V., Li, J., Panda, S. K., Huang, H., & Luyten, W. H. M. L. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03712-z · Cited by 17

Genotypic and phenotypic characteristics of Candida parapsilosis bloodstream isolates: Health Care Associated Infections in a teaching Hospital in Italy

Caggiano, G., Fioriti, S., Morroni, G., Apollonio, F., Triggiano, F., D’Achille, G., Stefanizzi, P., Dalfino, L., Ronga, L., Mosca, A., et al. (2024) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2024.04.009 · Cited by 18

The Transcriptional Aftermath in Two Independently Formed Hybrids of the Opportunistic Pathogen Candida orthopsilosis

Hovhannisyan, H., Saus, E., Księżopolska, E., & Gabaldón, T. (2020) · mSphere · doi:10.1128/msphere.00282-20 · Cited by 17

Threats from the Candida parapsilosis complex: the surge of multidrug resistance and a hotbed for new emerging pathogens

Gabaldón, T. (2024) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00029-23 · Cited by 15

Evaluation of MALDI-TOF MS for Identification of Species in the Candida parapsilosis Complex from Candidiasis Cases

Samantaray, S., & Singh, R. (2022) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfac005 · Cited by 14

Antimicrobial Resistance and Biofilms Underlying Catheter-Related Bloodstream Coinfection by Enterobacter cloacae Complex and Candida parapsilosis

Štefánek, M., Wenner, S., Borges, V., Pinto, M., Gomes, J. P., Rodrigues, J., de Faria, I. C. J., Pessanha, M. A., Martins, F., Sabino, R., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11091245 · Cited by 15

In vitro activity of sanitizers against mono- and polymicrobial biofilms of C. parapsilosis and S. aureus

Castro, V. D. P., Thomaz, D. Y., Vieira, K. D. L., Lopes, L. G., Rossi, F., Negro, G. M. B. D., Benard, G., & Pires, R. H. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00534-23 · Cited by 16

The Emerging Pathogen Candida metapsilosis: Biological Aspects, Virulence Factors, Diagnosis, and Treatment

Gómez-Gaviria, M., García-Carnero, L. C., Baruch-Martínez, D. A., & Mora-Montes, H. M. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s448213 · Cited by 20

Syngonanthus nitens (Bong.) Ruhland Derivatives Loaded into a Lipid Nanoemulsion for Enhanced Antifungal Activity Against Candida parapsilosis

de Lima, L. C., Ramos, M. A. D. S., de Toledo, L. G., Rodero, C. F., Hilário, F., dos Santos, L. C., Chorilli, M., & Bauab, T. M. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200317131041 · Cited by 15

Antifungal activity of 2-chloro-N-phenylacetamide: a new molecule with fungicidal and antibiofilm activity against fluconazole-resistant Candida spp.

Neto, H. D., Silva, S. L., Cordeiro, L. V., Silva, D. F., Oliveira, R., Filho, P. F. D. A., Filho, A. A. D. O., Guerra, F. Q. S., & Lima, E. D. O. (2022) · Brazilian Journal of Biology · doi:10.1590/1519-6984.255080 · Cited by 15

The transcription factor Ndt80 is a repressor of Candida parapsilosis virulence attributes

Branco, J., Martins-Cruz, C., Rodrigues, L., Silva, R. M., Araújo‐Gomes, N., Gonçalves, T., Miranda, I. M., & Rodrigues, A. G. (2021) · Virulence · doi:10.1080/21505594.2021.1878743 · Cited by 14

Signaling through Syk or CARD9 Mediates Species-Specific Anti-CandidaProtection in Bone Marrow Chimeric Mice

Zajta, E., Csonka, K., Tóth, A., Tiszlavicz, L., Németh, T., Orosz, A., Novák, Á., Csikós, M., Vágvölgyi, C., Mócsai, A., et al. (2021) · mBio · doi:10.1128/mbio.01608-21 · Cited by 16

Precise genome editing underlines the distinct contributions of mutations in ERG11 , ERG3 , MRR1 , and TAC1 genes to antifungal resistance in Candida parapsilosis

Hartuis, S., Ourliac‐Garnier, I., Robert, E., Albassier, M., Duchesne, L., Beaufils, C., Kuhn, J., Pape, P. L., & Morio, F. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00022-24 · Cited by 13

Epidemiology And Antifungal Susceptibility Patterns Of Invasive Fungal Infections From 2012 To 2014 In A Teaching Hospital In Central China

Xu, H., Yu, S.-Y., Zhou, M., Ning, Y., Xiao, M., Li, X.-G., Chen, M., Kong, F., Chen, S. C.-J., Ming, L., et al. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s227839 · Cited by 13

A Candida parapsilosis Overexpression Collection Reveals Genes Required for Pathogenesis

Pál, S. E., Tóth, R., Nosanchuk, J. D., Vágvölgyi, C., Németh, T., & Gácser, A. (2021) · Journal of Fungi · doi:10.3390/jof7020097 · Cited by 14

Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility

Asbeck, E. C. V., Clemons, K. V., & Stevens, D. A. (2009) · Critical Reviews in Microbiology · doi:10.3109/10408410903213393 · Cited by 216

Genetic Manipulation as a Tool to Unravel Candida parapsilosis Species Complex Virulence and Drug Resistance: State of the Art

Zoppo, M., Poma, N. V., Luca, M. D., Bottai, D., & Tavanti, A. (2021) · Journal of Fungi · doi:10.3390/jof7060459 · Cited by 14

Dissection of genotype-phenotype relationships in Candida parapsilosis uncovers drivers of clinically-relevant traitsPreprint

Schikora-Tamarit, M. À., López‐Peralta, E., Roldán, A., de Armentia, C., Torres-Cano, A., Alcázar‐Fuoli, L., CAPAR Study Group, Zaragoza, O., & Gabaldón, T. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.18.725882 · Cited by 1

Molecular epidemiology and antifungal susceptibility of Candida parapsilosis sensu stricto, Candida orthopsilosis, and Candida metapsilosis in Taiwan

Chen, Y., Lin, Y.-H., Chen, K.-W., Lii, J., Teng, H., & Li, S. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.07.004 · Cited by 56

Epidemiology and Antifungal Susceptibility of Candida Species

Chakraborty, M., Banu, H., & Gupta, M. K. (2021) · doi:10.13140/rg.2.2.32189.18400